NICE-approved weight management options for eligible NHS patients currently include semaglutide and tirzepatide
GLP-1 drugs have unexpectedly been found to potentially help with addiction disorders such as those associated with nicotine and other substances (Manalac, Dec 2024)
the three-entity structure (platform, clinical network, pharmacy) is named in legal documentation
Obesity-related healthcare spending averages $1,861 per person per year above healthy-weight peers, in 2019 dollars, according to the CDC
We designed the study within the ECOG-ACRIN TMIST population, which includes more than 108,000 women worldwide who have been recruited, characterized for breast cancer risk, and undergoing regular screening for breast cancer, she said
Compounded GLP-1 Medication is Risky While the obvious risks of compounded medications are that they are not FDA-tested or approved, Dr